{"gene":"CRIP1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1996,"finding":"NMR solution structure of CRIP (rat ortholog of human CRIP1) determined: the 76-residue LIM-domain protein binds two zinc ions via CCHC and CCCC modules forming orthogonally-arrayed antiparallel beta-sheets that pack via hydrophobic interactions into a compact fold.","method":"Homonuclear and 1H-15N heteronuclear NMR spectroscopy with 500 NOE-derived distance restraints","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — full NMR structure with detailed stereospecific assignments and mutagenic validation of zinc-coordination residues","pmids":["8632452"],"is_preprint":false},{"year":2007,"finding":"CRIP1a (and CRIP1b), generated by alternative splicing, bind the distal C-terminal tail of the CB1 cannabinoid receptor; CRIP1a co-immunoprecipitates with CB1 from rat brain homogenates, and CRIP1a (but not CRIP1b) suppresses CB1-mediated tonic inhibition of voltage-gated Ca2+ channels in superior cervical ganglion neurons.","method":"Co-immunoprecipitation from rat brain; co-injection of cDNAs in superior cervical ganglion neurons with electrophysiological readout","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP in native tissue plus functional electrophysiology rescue experiment","pmids":["17895407"],"is_preprint":false},{"year":2008,"finding":"In C. elegans, CRIP homologue EXC-9 maintains apical cytoskeletal flexibility in polarized epithelial cells to regulate tubule diameter; EXC-9 shows genetic interactions with EXC-5, a guanine exchange factor that regulates CDC-42 activity.","method":"Gene cloning, loss-of-function mutant analysis, genetic epistasis with exc-5/CDC-42 pathway","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in C. elegans ortholog with defined cellular phenotype, but single organism/lab","pmids":["18384766"],"is_preprint":false},{"year":2002,"finding":"Transgenic overexpression of CRIP in mice shifts cytokine balance toward Th2 (increased IL-6, IL-10; decreased IFN-γ, IL-2), reduces delayed-type hypersensitivity responses, and delays viral clearance, placing CRIP in a cellular pathway regulating Th1/Th2 cytokine balance.","method":"Transgenic mouse overexpression, LPS challenge, mitogen stimulation of splenocytes, influenza infection model","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transgenic model with multiple functional readouts, single lab","pmids":["12006348"],"is_preprint":false},{"year":2013,"finding":"CRIP1 knockdown in breast cancer cell lines (T47D, BT474) increases phosphorylation of MAPK and Akt, reduces phosphorylation of cdc2, elevates cell proliferation, and increases cell invasion, indicating CRIP1 normally suppresses these pro-malignant signaling pathways.","method":"siRNA knockdown, immunoblotting, WST-1 proliferation assay, invasion assay","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with specific signaling readouts in two cell lines, single lab","pmids":["23570421"],"is_preprint":false},{"year":2018,"finding":"CRIP1 promotes cell migration, invasion, and EMT in cervical cancer cells by activating the Wnt/β-catenin signaling pathway, increasing protein levels of c-Myc, CyclinD1, and cytoplasmic β-catenin.","method":"Transient transfection and siRNA knockdown, Western blot for EMT markers and Wnt pathway components, migration/invasion assays","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with defined pathway readouts, single lab","pmids":["29959029"],"is_preprint":false},{"year":2021,"finding":"Upon DNA damage, CRIP1 is deubiquitinated and upregulated by activated AKT signaling; CRIP1 then promotes nuclear enrichment of RAD51 by: (1) stabilizing BRCA2 to counteract FBXO5-targeted RAD51 degradation, and (2) binding the core domain of RAD51 (residues 184–257) together with BRCA2 to mask the RAD51 nuclear export signal; the importin KPNA4 controls nucleo-cytoplasmic distribution of the CRIP1-BRCA2-RAD51 complex.","method":"Co-immunoprecipitation, mass spectrometry, domain-mapping pulldown, shRNA knockdown, nuclear fractionation, in vitro homologous recombination assays, cisplatin/PARP-inhibitor sensitivity assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical methods (Co-IP, MS, domain mapping) plus functional HR assay and drug sensitivity, single lab with extensive controls","pmids":["34262130"],"is_preprint":false},{"year":2022,"finding":"CRIP1 interacts with BBOX1 and the E3 ubiquitin ligase STUB1, promoting K240 ubiquitination and proteasomal degradation of BBOX1, leading to reduced carnitine levels; decreased acetylcarnitine reduces β-catenin acetylation and promotes nuclear accumulation of β-catenin to drive hepatocellular carcinoma stem-like properties.","method":"Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis (K240R), mass spectrometry, cycloheximide chase, nuclear fractionation, acetylation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical reconstitution of ubiquitination with mutagenesis, multiple orthogonal methods, clear mechanistic chain","pmids":["35775648"],"is_preprint":false},{"year":2023,"finding":"CRIP1 binds NF-κB/p65 and facilitates its nuclear translocation in an importin-dependent manner, leading to transcriptional activation of CXCL1 and CXCL5, which promotes chemotactic MDSC migration and immunosuppression in pancreatic ductal adenocarcinoma.","method":"Co-immunoprecipitation, mass spectrometry, RNA sequencing, chromatin immunoprecipitation, orthotopic allograft model, flow cytometry","journal":"Gut","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (Co-IP/MS, ChIP, in vivo model) establishing CRIP1-p65 binding and downstream transcriptional consequence","pmids":["37541772"],"is_preprint":false},{"year":2023,"finding":"CRIP1 silencing in AML cells (U937 and THP1) inactivates the Wnt/β-catenin pathway through upregulation of Axin1 protein, and this phenotype is rescued by the Wnt/β-catenin agonist SKL2001.","method":"Lentiviral shRNA knockdown, Western blot for Axin1 and β-catenin targets, pharmacological rescue with SKL2001","journal":"Leukemia research","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with specific pathway readout and chemical rescue, single lab","pmids":["37224580"],"is_preprint":false},{"year":2024,"finding":"CRIP1 promotes proteasome activity and autophagosome maturation in multiple myeloma cells by simultaneously binding deubiquitinase USP7 and proteasome coactivator PA200, facilitating PA200 deubiquitination and stabilization.","method":"Co-immunoprecipitation, tandem affinity purification/mass spectrometry, RNA-seq, proteasome activity assay, autophagy flux assay, xenograft model","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 1–2 — TAP/MS identification of complex followed by functional validation of proteasome and autophagy activity, multiple orthogonal methods","pmids":["38199044"],"is_preprint":false},{"year":2025,"finding":"PRMT5-mediated symmetric dimethylation of CRIP1 at R26/R68 activates the Wnt/β-catenin pathway to facilitate stemness in senescent SCLC cells after early chemotherapy, while PRMT1-mediated asymmetric dimethylation of CRIP1 at R16 suppresses the p38 pathway to drive proliferation of stem-like cells at later chemotherapy stages; PELI1 E3 ligase regulates the PRMT1/PRMT5 balance.","method":"Mass spectrometry identification of methylation sites, site-directed mutagenesis (R16A, R26A, R68A), Western blot, PRMT inhibitor treatment, in vivo xenograft model","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 1–2 — MS-identified PTM sites with mutagenesis and downstream pathway readouts, single lab","pmids":["41079921"],"is_preprint":false},{"year":2025,"finding":"CRIP1 recruits E3 ubiquitin ligase UBE3A to MFGE8 in chondrocytes, promoting ubiquitination-dependent proteasomal degradation of MFGE8, which activates NF-κB (p65 phosphorylation) and extracellular matrix degradation in osteoarthritis.","method":"Immunoprecipitation/mass spectrometry for CRIP1 binding partners, co-immunoprecipitation, proteasome inhibitor rescue, cycloheximide chase, in vivo OA mouse model","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — IP/MS identification plus Co-IP and proteasome rescue experiments, single lab","pmids":["41067282"],"is_preprint":false},{"year":2025,"finding":"CRIP1 inhibits mitochondrial biogenesis in melanoma cells by suppressing TFAM protein levels, reducing mitochondrial DNA copy number, ATP production, respiratory capacity, and OXPHOS protein expression.","method":"Stable overexpression and knockdown, Western blot, immunofluorescence, OCR measurement, mitochondrial DNA assay, ATP assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with multiple orthogonal metabolic readouts identifying TFAM as downstream effector, single lab","pmids":["39905216"],"is_preprint":false},{"year":2024,"finding":"CRIP1 regulates osteogenic differentiation of bone marrow stromal cells through the Wnt signaling pathway; CRIP1 overexpression enhances osteogenic markers and rescues bone mass in ovariectomy-induced osteoporosis mice, while knockdown impairs alkaline phosphatase activity and mineralization.","method":"scRNA-seq of patient BMSCs, siRNA knockdown, overexpression, ALP assay, mineralization assay, ovariectomy mouse model","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function in vitro and in vivo with defined pathway, single lab","pmids":["38936225"],"is_preprint":false},{"year":2026,"finding":"In triple-negative breast cancer macrophages, HTRA1 associates with CRIP1, facilitating CRIP1 binding to NF-κB and activating downstream CXCL12 transcription, which drives T cell egress from tumors and limits immunotherapy efficacy.","method":"Co-immunoprecipitation, macrophage-specific Htra1 knockout mouse, single-cell and spatial transcriptomics, ChIP, orthotopic TNBC model","journal":"Cancer immunology research","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus genetic KO model with in vivo functional consequence, single lab","pmids":["41854522"],"is_preprint":false},{"year":1992,"finding":"CRIP (cysteine-rich intestinal protein, rodent ortholog) binds zinc in intestinal mucosa during absorption and functions as an intestinal zinc transport protein; high dietary zinc does not affect CRIP concentration but increases metallothionein, which may compete with CRIP for zinc.","method":"Biochemical zinc-binding assay, dietary zinc manipulation in vivo","journal":"Nutrition reviews","confidence":"Low","confidence_rationale":"Tier 3 — early biochemical characterization, single report, limited mechanistic detail","pmids":["1407754"],"is_preprint":false}],"current_model":"CRIP1 is a LIM/double-zinc-finger protein that acts as a multifunctional scaffold: it binds NF-κB/p65 to drive nuclear translocation and downstream chemokine transcription (CXCL1/5/12), interacts with BRCA2–RAD51 to promote nuclear enrichment of RAD51 and homologous recombination repair, recruits E3 ligases (STUB1, UBE3A) to direct ubiquitin-proteasome degradation of specific substrates (BBOX1, MFGE8), complexes with USP7 and PA200 to regulate proteasome activity and autophagy, is itself post-translationally modified by PRMT1/PRMT5-mediated arginine methylation to modulate Wnt/β-catenin and p38 pathway activity, and interacts with the CB1 cannabinoid receptor C-terminal tail to suppress tonic Ca2+-channel inhibition in neurons."},"narrative":{"teleology":[{"year":1992,"claim":"Initial characterization identified the rodent CRIP ortholog as a zinc-binding protein in intestinal mucosa, raising the possibility it participates in zinc transport.","evidence":"Biochemical zinc-binding assay and dietary zinc manipulation in rodents","pmids":["1407754"],"confidence":"Low","gaps":["Single early report with limited mechanistic detail","No demonstration of zinc transport activity in reconstituted system","Relevance to human CRIP1 function not established"]},{"year":1996,"claim":"Determination of the NMR solution structure established that CRIP1 folds into a compact LIM domain with two zinc-binding modules (CCHC and CCCC), providing the structural framework for understanding its protein-interaction surfaces.","evidence":"Homonuclear and heteronuclear NMR spectroscopy of rat CRIP with 500 NOE-derived distance restraints","pmids":["8632452"],"confidence":"High","gaps":["No co-structure with any binding partner","How the two zinc-finger modules contribute to distinct interactions remained undefined"]},{"year":2002,"claim":"Transgenic overexpression in mice revealed that CRIP1 shifts the Th1/Th2 cytokine balance toward Th2, establishing its first in vivo immunomodulatory role.","evidence":"Transgenic mouse overexpression with LPS challenge, mitogen stimulation, and influenza infection model","pmids":["12006348"],"confidence":"Medium","gaps":["Mechanism linking CRIP1 to cytokine gene regulation was unknown","Loss-of-function complement not performed"]},{"year":2007,"claim":"Discovery that CRIP1a binds the CB1 cannabinoid receptor C-terminal tail and attenuates tonic Ca²⁺-channel inhibition in neurons revealed a neuronal signaling function for this LIM protein.","evidence":"Co-immunoprecipitation from rat brain and electrophysiology in superior cervical ganglion neurons","pmids":["17895407"],"confidence":"High","gaps":["Structural basis of CRIP1a–CB1 interaction unresolved","Physiological consequence of CRIP1a–CB1 interaction in vivo not tested"]},{"year":2008,"claim":"Genetic analysis of the C. elegans CRIP homolog EXC-9 linked the LIM-domain family to apical cytoskeletal regulation and epithelial tube morphogenesis, demonstrating ancestral cytoskeletal scaffold function.","evidence":"Loss-of-function mutant analysis and genetic epistasis with EXC-5/CDC-42 pathway in C. elegans","pmids":["18384766"],"confidence":"Medium","gaps":["Direct relevance to mammalian CRIP1 cytoskeletal function not demonstrated","Biochemical mechanism of cytoskeletal regulation not defined"]},{"year":2013,"claim":"CRIP1 knockdown in breast cancer cells increased MAPK and Akt phosphorylation and enhanced proliferation/invasion, providing the first evidence that CRIP1 restrains oncogenic signaling in specific contexts.","evidence":"siRNA knockdown with immunoblotting and functional assays in T47D and BT474 cells","pmids":["23570421"],"confidence":"Medium","gaps":["No direct binding partner or mechanism for MAPK/Akt suppression identified","Context-dependent: opposite role seen in other cancers"]},{"year":2018,"claim":"Gain- and loss-of-function experiments in cervical cancer cells established that CRIP1 activates the Wnt/β-catenin pathway, promoting EMT and increasing c-Myc and CyclinD1 — the first link between CRIP1 and canonical Wnt signaling.","evidence":"Transient transfection, siRNA knockdown, and Western blot for Wnt pathway components in cervical cancer cells","pmids":["29959029"],"confidence":"Medium","gaps":["Direct molecular mechanism linking CRIP1 to β-catenin stabilization was unknown at this point"]},{"year":2021,"claim":"Identification of a CRIP1–BRCA2–RAD51 ternary complex showed how CRIP1 promotes homologous recombination repair: it stabilizes BRCA2, masks the RAD51 nuclear export signal, and facilitates KPNA4-dependent nuclear enrichment of RAD51 after DNA damage.","evidence":"Co-IP, mass spectrometry, domain mapping, shRNA knockdown, nuclear fractionation, HR assays, cisplatin/PARP-inhibitor sensitivity assays","pmids":["34262130"],"confidence":"High","gaps":["Structural details of CRIP1–RAD51 core-domain interaction unresolved","Whether CRIP1 participates in other repair pathways not addressed"]},{"year":2022,"claim":"CRIP1 was shown to recruit the E3 ligase STUB1 to BBOX1, directing K240 ubiquitination and proteasomal degradation that reduces carnitine levels and β-catenin acetylation — mechanistically explaining CRIP1-driven Wnt activation in hepatocellular carcinoma.","evidence":"Co-IP, ubiquitination assay with K240R mutagenesis, mass spectrometry, cycloheximide chase, acetylation assay in HCC cells","pmids":["35775648"],"confidence":"High","gaps":["Whether the BBOX1–carnitine–acetylation axis operates in non-hepatic contexts unknown","CRIP1 domain residues mediating STUB1 recruitment not mapped"]},{"year":2023,"claim":"Two studies consolidated the NF-κB axis: CRIP1 binds p65 and facilitates its importin-dependent nuclear translocation, activating CXCL1/CXCL5 transcription in pancreatic cancer and contributing to immunosuppressive MDSC recruitment, while separate work confirmed Wnt/β-catenin pathway dependence in AML through Axin1 regulation.","evidence":"Co-IP/MS, ChIP, RNA-seq, orthotopic allograft model (pancreatic cancer); shRNA knockdown with pharmacological rescue in AML cells","pmids":["37541772","37224580"],"confidence":"High","gaps":["Whether p65 and β-catenin pathways are independently or coordinately regulated by CRIP1 not resolved","Importin isoform specificity for CRIP1–p65 translocation not fully defined"]},{"year":2024,"claim":"CRIP1 was found to bridge USP7 and PA200, promoting PA200 deubiquitination and stabilization, thereby enhancing proteasome activity and autophagosome maturation in myeloma — revealing a role in protein homeostasis machinery.","evidence":"TAP/MS, Co-IP, proteasome activity assay, autophagy flux assay, xenograft model in multiple myeloma","pmids":["38199044"],"confidence":"High","gaps":["Whether CRIP1–USP7–PA200 complex formation is regulated by post-translational modifications not explored","Contribution to proteasome activity in non-malignant cells unknown"]},{"year":2024,"claim":"CRIP1 was shown to regulate osteogenic differentiation of bone marrow stromal cells through Wnt signaling, with in vivo rescue of ovariectomy-induced bone loss by CRIP1 overexpression.","evidence":"scRNA-seq, siRNA/overexpression, ALP and mineralization assays, ovariectomy mouse model","pmids":["38936225"],"confidence":"Medium","gaps":["Specific Wnt pathway components controlled by CRIP1 in osteoblasts not identified","Whether BBOX1 or Axin1 mechanisms apply in this context untested"]},{"year":2025,"claim":"PRMT1 and PRMT5 were identified as writers of distinct arginine methylation marks on CRIP1 (R16 asymmetric by PRMT1; R26/R68 symmetric by PRMT5), differentially controlling p38 and Wnt/β-catenin pathways during chemotherapy-induced stemness in SCLC — establishing that CRIP1 function is post-translationally tuned.","evidence":"MS-identified methylation sites, site-directed mutagenesis, PRMT inhibitor treatment, xenograft model","pmids":["41079921"],"confidence":"Medium","gaps":["Readers of CRIP1 methylation marks not identified","Whether arginine methylation affects CRIP1 interactions with known partners (BRCA2, p65, STUB1) untested"]},{"year":2025,"claim":"CRIP1 was shown to recruit UBE3A to MFGE8 for ubiquitin-dependent degradation in chondrocytes, activating NF-κB and ECM degradation in osteoarthritis — a second E3 ligase adaptor function paralleling the STUB1–BBOX1 axis.","evidence":"IP/MS, Co-IP, proteasome inhibitor rescue, cycloheximide chase, OA mouse model","pmids":["41067282"],"confidence":"Medium","gaps":["Structural basis of CRIP1 recruiting distinct E3 ligases to different substrates unknown","Only single-lab validation"]},{"year":2025,"claim":"CRIP1 suppresses TFAM protein levels in melanoma, reducing mitochondrial DNA copy number and OXPHOS — adding mitochondrial biogenesis regulation to its functional repertoire.","evidence":"Stable overexpression/knockdown, OCR measurement, mitochondrial DNA assay, ATP assay in melanoma cells","pmids":["39905216"],"confidence":"Medium","gaps":["Mechanism of TFAM suppression (transcriptional vs. post-translational) not determined","Whether this involves ubiquitin-dependent degradation like BBOX1/MFGE8 is untested"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for how the compact CRIP1 LIM domain engages its many diverse partners (p65, BRCA2, RAD51, STUB1, UBE3A, USP7, PA200, CB1); how arginine methylation by PRMT1/PRMT5 modulates partner selectivity; and whether CRIP1's E3 ligase adaptor function is a general scaffolding mechanism or restricted to specific substrates.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal or cryo-EM structure of CRIP1 with any partner","No systematic unbiased interactome in non-cancer cells","Integration of methylation code with substrate/partner specificity untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,7,10,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,8,10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,8]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,7]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,5,7,9,11,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,8,15]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[7,10,12]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[10]}],"complexes":["CRIP1–BRCA2–RAD51","CRIP1–USP7–PA200"],"partners":["RELA","BRCA2","RAD51","STUB1","USP7","UBE3A","CNR1","HTRA1"],"other_free_text":[]},"mechanistic_narrative":"CRIP1 is a compact LIM/double-zinc-finger scaffold protein that orchestrates diverse signaling and protein-quality-control pathways by bridging transcription factors, DNA-repair complexes, E3 ubiquitin ligases, and deubiquitinases to their respective substrates. CRIP1 binds NF-κB/p65 and promotes its importin-dependent nuclear translocation, driving transcription of chemokines CXCL1, CXCL5, and CXCL12 in tumor microenvironments [PMID:37541772, PMID:41854522]; it also activates Wnt/β-catenin signaling through multiple mechanisms, including recruiting the E3 ligase STUB1 to ubiquitinate and degrade BBOX1, thereby reducing β-catenin acetylation and enhancing its nuclear accumulation [PMID:35775648], and through Axin1 regulation [PMID:37224580]. In the DNA damage response, CRIP1 forms a ternary complex with BRCA2 and RAD51, masking the RAD51 nuclear export signal and promoting homologous recombination repair [PMID:34262130]; separately, it bridges USP7 and the proteasome coactivator PA200 to stimulate proteasome activity and autophagosome maturation [PMID:38199044], and its own arginine methylation by PRMT1 and PRMT5 at distinct residues differentially controls Wnt/β-catenin and p38 pathway outputs [PMID:41079921]."},"prefetch_data":{"uniprot":{"accession":"P50238","full_name":"Cysteine-rich protein 1","aliases":["Cysteine-rich heart protein","CRHP","hCRHP","Cysteine-rich intestinal protein","CRIP"],"length_aa":77,"mass_kda":8.5,"function":"Seems to have a role in zinc absorption and may function as an intracellular zinc transport protein","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P50238/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CRIP1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CRIP1","total_profiled":1310},"omim":[{"mim_id":"618538","title":"CANNABINOID RECEPTOR-INTERACTING PROTEIN 1; CNRIP1","url":"https://www.omim.org/entry/618538"},{"mim_id":"609096","title":"F-BOX ONLY PROTEIN 22; FBXO22","url":"https://www.omim.org/entry/609096"},{"mim_id":"601183","title":"CYSTEINE-RICH INTESTINAL PROTEIN 2; CRIP2","url":"https://www.omim.org/entry/601183"},{"mim_id":"123875","title":"CYSTEINE-RICH INTESTINAL PROTEIN 1; CRIP1","url":"https://www.omim.org/entry/123875"},{"mim_id":"114610","title":"CANNABINOID RECEPTOR 1; CNR1","url":"https://www.omim.org/entry/114610"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":548.9}],"url":"https://www.proteinatlas.org/search/CRIP1"},"hgnc":{"alias_symbol":["CRIP"],"prev_symbol":[]},"alphafold":{"accession":"P50238","domains":[{"cath_id":"2.10.110.10","chopping":"15-59","consensus_level":"high","plddt":88.6238,"start":15,"end":59}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P50238","model_url":"https://alphafold.ebi.ac.uk/files/AF-P50238-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P50238-F1-predicted_aligned_error_v6.png","plddt_mean":81.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CRIP1","jax_strain_url":"https://www.jax.org/strain/search?query=CRIP1"},"sequence":{"accession":"P50238","fasta_url":"https://rest.uniprot.org/uniprotkb/P50238.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P50238/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P50238"}},"corpus_meta":[{"pmid":"17486081","id":"PMC_17486081","title":"Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17486081","citation_count":117,"is_preprint":false},{"pmid":"17895407","id":"PMC_17895407","title":"CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a.","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17895407","citation_count":112,"is_preprint":false},{"pmid":"37541772","id":"PMC_37541772","title":"CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.","date":"2023","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/37541772","citation_count":86,"is_preprint":false},{"pmid":"31537716","id":"PMC_31537716","title":"CRIP: predicting circRNA-RBP-binding sites using a codon-based encoding and hybrid deep neural networks.","date":"2019","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31537716","citation_count":73,"is_preprint":false},{"pmid":"8632452","id":"PMC_8632452","title":"Structure of the cysteine-rich intestinal protein, CRIP.","date":"1996","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8632452","citation_count":54,"is_preprint":false},{"pmid":"35775648","id":"PMC_35775648","title":"CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma.","date":"2022","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/35775648","citation_count":52,"is_preprint":false},{"pmid":"18670594","id":"PMC_18670594","title":"Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers.","date":"2008","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/18670594","citation_count":49,"is_preprint":false},{"pmid":"23570421","id":"PMC_23570421","title":"The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.","date":"2013","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23570421","citation_count":45,"is_preprint":false},{"pmid":"12006348","id":"PMC_12006348","title":"Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response.","date":"2002","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12006348","citation_count":42,"is_preprint":false},{"pmid":"29959029","id":"PMC_29959029","title":"CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29959029","citation_count":38,"is_preprint":false},{"pmid":"22202598","id":"PMC_22202598","title":"CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients.","date":"2011","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/22202598","citation_count":30,"is_preprint":false},{"pmid":"34262130","id":"PMC_34262130","title":"CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34262130","citation_count":30,"is_preprint":false},{"pmid":"8593605","id":"PMC_8593605","title":"Activation of Moloney murine leukemia virus LTR enhances the titer of recombinant retrovirus in psi CRIP packaging cells.","date":"1995","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/8593605","citation_count":21,"is_preprint":false},{"pmid":"18384766","id":"PMC_18384766","title":"CRIP homologues maintain apical cytoskeleton to regulate tubule size in C. elegans.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18384766","citation_count":19,"is_preprint":false},{"pmid":"38199044","id":"PMC_38199044","title":"CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy.","date":"2024","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/38199044","citation_count":18,"is_preprint":false},{"pmid":"31419938","id":"PMC_31419938","title":"Genome-wide identification of AGO18b-bound miRNAs and phasiRNAs in maize by cRIP-seq.","date":"2019","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31419938","citation_count":17,"is_preprint":false},{"pmid":"29059670","id":"PMC_29059670","title":"The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29059670","citation_count":16,"is_preprint":false},{"pmid":"9480758","id":"PMC_9480758","title":"Mapping of the human cysteine-rich intestinal protein gene CRIP1 to the human chromosomal segment 7q11.23.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9480758","citation_count":13,"is_preprint":false},{"pmid":"24328073","id":"PMC_24328073","title":"Combining peptide and DNA for protein assay: CRIP1 detection for breast cancer staging.","date":"2013","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/24328073","citation_count":13,"is_preprint":false},{"pmid":"27836662","id":"PMC_27836662","title":"CRIP1, a novel immune-related protein, activated by Enterococcus faecalis in porcine gastrointestinal epithelial cells.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27836662","citation_count":9,"is_preprint":false},{"pmid":"33782695","id":"PMC_33782695","title":"CRIP1 expression in monocytes related to hypertension.","date":"2021","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/33782695","citation_count":9,"is_preprint":false},{"pmid":"37224580","id":"PMC_37224580","title":"CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway.","date":"2023","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/37224580","citation_count":8,"is_preprint":false},{"pmid":"37390825","id":"PMC_37390825","title":"Single-cell analysis of human fetal epicardium reveals its cellular composition and identifies CRIP1 as a modulator of EMT.","date":"2023","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37390825","citation_count":8,"is_preprint":false},{"pmid":"26154325","id":"PMC_26154325","title":"Comparative expression analysis of cysteine-rich intestinal protein family members crip1, 2 and 3 during Xenopus laevis embryogenesis.","date":"2014","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26154325","citation_count":8,"is_preprint":false},{"pmid":"1407754","id":"PMC_1407754","title":"Cysteine-rich intestinal protein (CRIP): a new intestinal zinc transport protein.","date":"1992","source":"Nutrition reviews","url":"https://pubmed.ncbi.nlm.nih.gov/1407754","citation_count":7,"is_preprint":false},{"pmid":"35938037","id":"PMC_35938037","title":"Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35938037","citation_count":6,"is_preprint":false},{"pmid":"35140819","id":"PMC_35140819","title":"Comprehensive Analysis of CRIP1 in Patients with Ovarian Cancer, including ceRNA Network, Immune-Infiltration Pattern, and Clinical Benefit.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/35140819","citation_count":4,"is_preprint":false},{"pmid":"38936225","id":"PMC_38936225","title":"CRIP1 regulates osteogenic differentiation of bone marrow stromal cells and pre-osteoblasts via the Wnt signaling pathway.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/38936225","citation_count":3,"is_preprint":false},{"pmid":"39905216","id":"PMC_39905216","title":"CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39905216","citation_count":3,"is_preprint":false},{"pmid":"41079921","id":"PMC_41079921","title":"PRMT1/PRMT5-Mediated Differential Arginine Methylation of CRIP1 Promotes the Recurrence of Small Cell Lung Cancer after Chemotherapy.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41079921","citation_count":1,"is_preprint":false},{"pmid":"41854522","id":"PMC_41854522","title":"HTRA1+ macrophages induce T cells egress through CRIP1/NF-κB/CXCL12 to limit the effects of immunotherapy in triple-negative breast cancer.","date":"2026","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/41854522","citation_count":0,"is_preprint":false},{"pmid":"41988531","id":"PMC_41988531","title":"CRIP1 promotes docetaxel resistance and immune-associated cell death modulation in prostate cancer.","date":"2026","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41988531","citation_count":0,"is_preprint":false},{"pmid":"41107987","id":"PMC_41107987","title":"Discovering CRIP1: a novel core gene in osteoarthritis pathogenesis.","date":"2025","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/41107987","citation_count":0,"is_preprint":false},{"pmid":"41067282","id":"PMC_41067282","title":"CRIP1 exacerbates osteoarthritis progression by recruiting UBE3A to induce the ubiquitination-mediated degradation of MFGE8.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41067282","citation_count":0,"is_preprint":false},{"pmid":"41670839","id":"PMC_41670839","title":"CRIP1 knockdown enhances glycolytic dependence and increases sensitivity to 2-Deoxy-D-Glucose in acute myeloid leukemia.","date":"2026","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/41670839","citation_count":0,"is_preprint":false},{"pmid":"21816589","id":"PMC_21816589","title":"[The Paris cell for collecting preoccupying information (la CRIP 75): an organization at the heart of child protection].","date":"2011","source":"Archives de pediatrie : organe officiel de la Societe francaise de pediatrie","url":"https://pubmed.ncbi.nlm.nih.gov/21816589","citation_count":0,"is_preprint":false},{"pmid":"41972184","id":"PMC_41972184","title":"Molecular insights into CRIP1 as an immunometabolic regulator revealed by CRIP1 knockout and single-cell transcriptomics.","date":"2026","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41972184","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.08.25337413","title":"Multi-scale integration of human brain vascular and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy linked to Alzheimer’s disease risk","date":"2025-10-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.08.25337413","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.18.24312185","title":"Genetics of transient amnesia highlights a vascular role in memory","date":"2024-08-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.18.24312185","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.09.593462","title":"Construction of a breast cancer predictive nomogram based on diverse cell death methods and reveal tumor microenvironment characterization","date":"2024-05-14","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.09.593462","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.22.25340784","title":"Genetic–exposome axis orchestrates cardiac motion patterns","date":"2025-11-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.22.25340784","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.04.25332945","title":"Proteomic signatures of the <i>APOE ε4</i> and <i>APOE ε2</i> genetic variants and Alzheimer’s disease","date":"2025-08-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.04.25332945","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21720,"output_tokens":4053,"usd":0.062978},"stage2":{"model":"claude-opus-4-6","input_tokens":7553,"output_tokens":3787,"usd":0.19866},"total_usd":0.261638,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"NMR solution structure of CRIP (rat ortholog of human CRIP1) determined: the 76-residue LIM-domain protein binds two zinc ions via CCHC and CCCC modules forming orthogonally-arrayed antiparallel beta-sheets that pack via hydrophobic interactions into a compact fold.\",\n      \"method\": \"Homonuclear and 1H-15N heteronuclear NMR spectroscopy with 500 NOE-derived distance restraints\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — full NMR structure with detailed stereospecific assignments and mutagenic validation of zinc-coordination residues\",\n      \"pmids\": [\"8632452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CRIP1a (and CRIP1b), generated by alternative splicing, bind the distal C-terminal tail of the CB1 cannabinoid receptor; CRIP1a co-immunoprecipitates with CB1 from rat brain homogenates, and CRIP1a (but not CRIP1b) suppresses CB1-mediated tonic inhibition of voltage-gated Ca2+ channels in superior cervical ganglion neurons.\",\n      \"method\": \"Co-immunoprecipitation from rat brain; co-injection of cDNAs in superior cervical ganglion neurons with electrophysiological readout\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP in native tissue plus functional electrophysiology rescue experiment\",\n      \"pmids\": [\"17895407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In C. elegans, CRIP homologue EXC-9 maintains apical cytoskeletal flexibility in polarized epithelial cells to regulate tubule diameter; EXC-9 shows genetic interactions with EXC-5, a guanine exchange factor that regulates CDC-42 activity.\",\n      \"method\": \"Gene cloning, loss-of-function mutant analysis, genetic epistasis with exc-5/CDC-42 pathway\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in C. elegans ortholog with defined cellular phenotype, but single organism/lab\",\n      \"pmids\": [\"18384766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Transgenic overexpression of CRIP in mice shifts cytokine balance toward Th2 (increased IL-6, IL-10; decreased IFN-γ, IL-2), reduces delayed-type hypersensitivity responses, and delays viral clearance, placing CRIP in a cellular pathway regulating Th1/Th2 cytokine balance.\",\n      \"method\": \"Transgenic mouse overexpression, LPS challenge, mitogen stimulation of splenocytes, influenza infection model\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with multiple functional readouts, single lab\",\n      \"pmids\": [\"12006348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CRIP1 knockdown in breast cancer cell lines (T47D, BT474) increases phosphorylation of MAPK and Akt, reduces phosphorylation of cdc2, elevates cell proliferation, and increases cell invasion, indicating CRIP1 normally suppresses these pro-malignant signaling pathways.\",\n      \"method\": \"siRNA knockdown, immunoblotting, WST-1 proliferation assay, invasion assay\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific signaling readouts in two cell lines, single lab\",\n      \"pmids\": [\"23570421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CRIP1 promotes cell migration, invasion, and EMT in cervical cancer cells by activating the Wnt/β-catenin signaling pathway, increasing protein levels of c-Myc, CyclinD1, and cytoplasmic β-catenin.\",\n      \"method\": \"Transient transfection and siRNA knockdown, Western blot for EMT markers and Wnt pathway components, migration/invasion assays\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with defined pathway readouts, single lab\",\n      \"pmids\": [\"29959029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Upon DNA damage, CRIP1 is deubiquitinated and upregulated by activated AKT signaling; CRIP1 then promotes nuclear enrichment of RAD51 by: (1) stabilizing BRCA2 to counteract FBXO5-targeted RAD51 degradation, and (2) binding the core domain of RAD51 (residues 184–257) together with BRCA2 to mask the RAD51 nuclear export signal; the importin KPNA4 controls nucleo-cytoplasmic distribution of the CRIP1-BRCA2-RAD51 complex.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, domain-mapping pulldown, shRNA knockdown, nuclear fractionation, in vitro homologous recombination assays, cisplatin/PARP-inhibitor sensitivity assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical methods (Co-IP, MS, domain mapping) plus functional HR assay and drug sensitivity, single lab with extensive controls\",\n      \"pmids\": [\"34262130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CRIP1 interacts with BBOX1 and the E3 ubiquitin ligase STUB1, promoting K240 ubiquitination and proteasomal degradation of BBOX1, leading to reduced carnitine levels; decreased acetylcarnitine reduces β-catenin acetylation and promotes nuclear accumulation of β-catenin to drive hepatocellular carcinoma stem-like properties.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis (K240R), mass spectrometry, cycloheximide chase, nuclear fractionation, acetylation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical reconstitution of ubiquitination with mutagenesis, multiple orthogonal methods, clear mechanistic chain\",\n      \"pmids\": [\"35775648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CRIP1 binds NF-κB/p65 and facilitates its nuclear translocation in an importin-dependent manner, leading to transcriptional activation of CXCL1 and CXCL5, which promotes chemotactic MDSC migration and immunosuppression in pancreatic ductal adenocarcinoma.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, RNA sequencing, chromatin immunoprecipitation, orthotopic allograft model, flow cytometry\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (Co-IP/MS, ChIP, in vivo model) establishing CRIP1-p65 binding and downstream transcriptional consequence\",\n      \"pmids\": [\"37541772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CRIP1 silencing in AML cells (U937 and THP1) inactivates the Wnt/β-catenin pathway through upregulation of Axin1 protein, and this phenotype is rescued by the Wnt/β-catenin agonist SKL2001.\",\n      \"method\": \"Lentiviral shRNA knockdown, Western blot for Axin1 and β-catenin targets, pharmacological rescue with SKL2001\",\n      \"journal\": \"Leukemia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific pathway readout and chemical rescue, single lab\",\n      \"pmids\": [\"37224580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CRIP1 promotes proteasome activity and autophagosome maturation in multiple myeloma cells by simultaneously binding deubiquitinase USP7 and proteasome coactivator PA200, facilitating PA200 deubiquitination and stabilization.\",\n      \"method\": \"Co-immunoprecipitation, tandem affinity purification/mass spectrometry, RNA-seq, proteasome activity assay, autophagy flux assay, xenograft model\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — TAP/MS identification of complex followed by functional validation of proteasome and autophagy activity, multiple orthogonal methods\",\n      \"pmids\": [\"38199044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PRMT5-mediated symmetric dimethylation of CRIP1 at R26/R68 activates the Wnt/β-catenin pathway to facilitate stemness in senescent SCLC cells after early chemotherapy, while PRMT1-mediated asymmetric dimethylation of CRIP1 at R16 suppresses the p38 pathway to drive proliferation of stem-like cells at later chemotherapy stages; PELI1 E3 ligase regulates the PRMT1/PRMT5 balance.\",\n      \"method\": \"Mass spectrometry identification of methylation sites, site-directed mutagenesis (R16A, R26A, R68A), Western blot, PRMT inhibitor treatment, in vivo xenograft model\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — MS-identified PTM sites with mutagenesis and downstream pathway readouts, single lab\",\n      \"pmids\": [\"41079921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRIP1 recruits E3 ubiquitin ligase UBE3A to MFGE8 in chondrocytes, promoting ubiquitination-dependent proteasomal degradation of MFGE8, which activates NF-κB (p65 phosphorylation) and extracellular matrix degradation in osteoarthritis.\",\n      \"method\": \"Immunoprecipitation/mass spectrometry for CRIP1 binding partners, co-immunoprecipitation, proteasome inhibitor rescue, cycloheximide chase, in vivo OA mouse model\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — IP/MS identification plus Co-IP and proteasome rescue experiments, single lab\",\n      \"pmids\": [\"41067282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRIP1 inhibits mitochondrial biogenesis in melanoma cells by suppressing TFAM protein levels, reducing mitochondrial DNA copy number, ATP production, respiratory capacity, and OXPHOS protein expression.\",\n      \"method\": \"Stable overexpression and knockdown, Western blot, immunofluorescence, OCR measurement, mitochondrial DNA assay, ATP assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with multiple orthogonal metabolic readouts identifying TFAM as downstream effector, single lab\",\n      \"pmids\": [\"39905216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CRIP1 regulates osteogenic differentiation of bone marrow stromal cells through the Wnt signaling pathway; CRIP1 overexpression enhances osteogenic markers and rescues bone mass in ovariectomy-induced osteoporosis mice, while knockdown impairs alkaline phosphatase activity and mineralization.\",\n      \"method\": \"scRNA-seq of patient BMSCs, siRNA knockdown, overexpression, ALP assay, mineralization assay, ovariectomy mouse model\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function in vitro and in vivo with defined pathway, single lab\",\n      \"pmids\": [\"38936225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In triple-negative breast cancer macrophages, HTRA1 associates with CRIP1, facilitating CRIP1 binding to NF-κB and activating downstream CXCL12 transcription, which drives T cell egress from tumors and limits immunotherapy efficacy.\",\n      \"method\": \"Co-immunoprecipitation, macrophage-specific Htra1 knockout mouse, single-cell and spatial transcriptomics, ChIP, orthotopic TNBC model\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus genetic KO model with in vivo functional consequence, single lab\",\n      \"pmids\": [\"41854522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CRIP (cysteine-rich intestinal protein, rodent ortholog) binds zinc in intestinal mucosa during absorption and functions as an intestinal zinc transport protein; high dietary zinc does not affect CRIP concentration but increases metallothionein, which may compete with CRIP for zinc.\",\n      \"method\": \"Biochemical zinc-binding assay, dietary zinc manipulation in vivo\",\n      \"journal\": \"Nutrition reviews\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — early biochemical characterization, single report, limited mechanistic detail\",\n      \"pmids\": [\"1407754\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CRIP1 is a LIM/double-zinc-finger protein that acts as a multifunctional scaffold: it binds NF-κB/p65 to drive nuclear translocation and downstream chemokine transcription (CXCL1/5/12), interacts with BRCA2–RAD51 to promote nuclear enrichment of RAD51 and homologous recombination repair, recruits E3 ligases (STUB1, UBE3A) to direct ubiquitin-proteasome degradation of specific substrates (BBOX1, MFGE8), complexes with USP7 and PA200 to regulate proteasome activity and autophagy, is itself post-translationally modified by PRMT1/PRMT5-mediated arginine methylation to modulate Wnt/β-catenin and p38 pathway activity, and interacts with the CB1 cannabinoid receptor C-terminal tail to suppress tonic Ca2+-channel inhibition in neurons.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CRIP1 is a compact LIM/double-zinc-finger scaffold protein that orchestrates diverse signaling and protein-quality-control pathways by bridging transcription factors, DNA-repair complexes, E3 ubiquitin ligases, and deubiquitinases to their respective substrates. CRIP1 binds NF-κB/p65 and promotes its importin-dependent nuclear translocation, driving transcription of chemokines CXCL1, CXCL5, and CXCL12 in tumor microenvironments [PMID:37541772, PMID:41854522]; it also activates Wnt/β-catenin signaling through multiple mechanisms, including recruiting the E3 ligase STUB1 to ubiquitinate and degrade BBOX1, thereby reducing β-catenin acetylation and enhancing its nuclear accumulation [PMID:35775648], and through Axin1 regulation [PMID:37224580]. In the DNA damage response, CRIP1 forms a ternary complex with BRCA2 and RAD51, masking the RAD51 nuclear export signal and promoting homologous recombination repair [PMID:34262130]; separately, it bridges USP7 and the proteasome coactivator PA200 to stimulate proteasome activity and autophagosome maturation [PMID:38199044], and its own arginine methylation by PRMT1 and PRMT5 at distinct residues differentially controls Wnt/β-catenin and p38 pathway outputs [PMID:41079921].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Initial characterization identified the rodent CRIP ortholog as a zinc-binding protein in intestinal mucosa, raising the possibility it participates in zinc transport.\",\n      \"evidence\": \"Biochemical zinc-binding assay and dietary zinc manipulation in rodents\",\n      \"pmids\": [\"1407754\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single early report with limited mechanistic detail\", \"No demonstration of zinc transport activity in reconstituted system\", \"Relevance to human CRIP1 function not established\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Determination of the NMR solution structure established that CRIP1 folds into a compact LIM domain with two zinc-binding modules (CCHC and CCCC), providing the structural framework for understanding its protein-interaction surfaces.\",\n      \"evidence\": \"Homonuclear and heteronuclear NMR spectroscopy of rat CRIP with 500 NOE-derived distance restraints\",\n      \"pmids\": [\"8632452\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-structure with any binding partner\", \"How the two zinc-finger modules contribute to distinct interactions remained undefined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Transgenic overexpression in mice revealed that CRIP1 shifts the Th1/Th2 cytokine balance toward Th2, establishing its first in vivo immunomodulatory role.\",\n      \"evidence\": \"Transgenic mouse overexpression with LPS challenge, mitogen stimulation, and influenza infection model\",\n      \"pmids\": [\"12006348\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking CRIP1 to cytokine gene regulation was unknown\", \"Loss-of-function complement not performed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that CRIP1a binds the CB1 cannabinoid receptor C-terminal tail and attenuates tonic Ca²⁺-channel inhibition in neurons revealed a neuronal signaling function for this LIM protein.\",\n      \"evidence\": \"Co-immunoprecipitation from rat brain and electrophysiology in superior cervical ganglion neurons\",\n      \"pmids\": [\"17895407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CRIP1a–CB1 interaction unresolved\", \"Physiological consequence of CRIP1a–CB1 interaction in vivo not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic analysis of the C. elegans CRIP homolog EXC-9 linked the LIM-domain family to apical cytoskeletal regulation and epithelial tube morphogenesis, demonstrating ancestral cytoskeletal scaffold function.\",\n      \"evidence\": \"Loss-of-function mutant analysis and genetic epistasis with EXC-5/CDC-42 pathway in C. elegans\",\n      \"pmids\": [\"18384766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct relevance to mammalian CRIP1 cytoskeletal function not demonstrated\", \"Biochemical mechanism of cytoskeletal regulation not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"CRIP1 knockdown in breast cancer cells increased MAPK and Akt phosphorylation and enhanced proliferation/invasion, providing the first evidence that CRIP1 restrains oncogenic signaling in specific contexts.\",\n      \"evidence\": \"siRNA knockdown with immunoblotting and functional assays in T47D and BT474 cells\",\n      \"pmids\": [\"23570421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct binding partner or mechanism for MAPK/Akt suppression identified\", \"Context-dependent: opposite role seen in other cancers\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Gain- and loss-of-function experiments in cervical cancer cells established that CRIP1 activates the Wnt/β-catenin pathway, promoting EMT and increasing c-Myc and CyclinD1 — the first link between CRIP1 and canonical Wnt signaling.\",\n      \"evidence\": \"Transient transfection, siRNA knockdown, and Western blot for Wnt pathway components in cervical cancer cells\",\n      \"pmids\": [\"29959029\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular mechanism linking CRIP1 to β-catenin stabilization was unknown at this point\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of a CRIP1–BRCA2–RAD51 ternary complex showed how CRIP1 promotes homologous recombination repair: it stabilizes BRCA2, masks the RAD51 nuclear export signal, and facilitates KPNA4-dependent nuclear enrichment of RAD51 after DNA damage.\",\n      \"evidence\": \"Co-IP, mass spectrometry, domain mapping, shRNA knockdown, nuclear fractionation, HR assays, cisplatin/PARP-inhibitor sensitivity assays\",\n      \"pmids\": [\"34262130\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural details of CRIP1–RAD51 core-domain interaction unresolved\", \"Whether CRIP1 participates in other repair pathways not addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CRIP1 was shown to recruit the E3 ligase STUB1 to BBOX1, directing K240 ubiquitination and proteasomal degradation that reduces carnitine levels and β-catenin acetylation — mechanistically explaining CRIP1-driven Wnt activation in hepatocellular carcinoma.\",\n      \"evidence\": \"Co-IP, ubiquitination assay with K240R mutagenesis, mass spectrometry, cycloheximide chase, acetylation assay in HCC cells\",\n      \"pmids\": [\"35775648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the BBOX1–carnitine–acetylation axis operates in non-hepatic contexts unknown\", \"CRIP1 domain residues mediating STUB1 recruitment not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Two studies consolidated the NF-κB axis: CRIP1 binds p65 and facilitates its importin-dependent nuclear translocation, activating CXCL1/CXCL5 transcription in pancreatic cancer and contributing to immunosuppressive MDSC recruitment, while separate work confirmed Wnt/β-catenin pathway dependence in AML through Axin1 regulation.\",\n      \"evidence\": \"Co-IP/MS, ChIP, RNA-seq, orthotopic allograft model (pancreatic cancer); shRNA knockdown with pharmacological rescue in AML cells\",\n      \"pmids\": [\"37541772\", \"37224580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p65 and β-catenin pathways are independently or coordinately regulated by CRIP1 not resolved\", \"Importin isoform specificity for CRIP1–p65 translocation not fully defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CRIP1 was found to bridge USP7 and PA200, promoting PA200 deubiquitination and stabilization, thereby enhancing proteasome activity and autophagosome maturation in myeloma — revealing a role in protein homeostasis machinery.\",\n      \"evidence\": \"TAP/MS, Co-IP, proteasome activity assay, autophagy flux assay, xenograft model in multiple myeloma\",\n      \"pmids\": [\"38199044\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CRIP1–USP7–PA200 complex formation is regulated by post-translational modifications not explored\", \"Contribution to proteasome activity in non-malignant cells unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CRIP1 was shown to regulate osteogenic differentiation of bone marrow stromal cells through Wnt signaling, with in vivo rescue of ovariectomy-induced bone loss by CRIP1 overexpression.\",\n      \"evidence\": \"scRNA-seq, siRNA/overexpression, ALP and mineralization assays, ovariectomy mouse model\",\n      \"pmids\": [\"38936225\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific Wnt pathway components controlled by CRIP1 in osteoblasts not identified\", \"Whether BBOX1 or Axin1 mechanisms apply in this context untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"PRMT1 and PRMT5 were identified as writers of distinct arginine methylation marks on CRIP1 (R16 asymmetric by PRMT1; R26/R68 symmetric by PRMT5), differentially controlling p38 and Wnt/β-catenin pathways during chemotherapy-induced stemness in SCLC — establishing that CRIP1 function is post-translationally tuned.\",\n      \"evidence\": \"MS-identified methylation sites, site-directed mutagenesis, PRMT inhibitor treatment, xenograft model\",\n      \"pmids\": [\"41079921\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Readers of CRIP1 methylation marks not identified\", \"Whether arginine methylation affects CRIP1 interactions with known partners (BRCA2, p65, STUB1) untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"CRIP1 was shown to recruit UBE3A to MFGE8 for ubiquitin-dependent degradation in chondrocytes, activating NF-κB and ECM degradation in osteoarthritis — a second E3 ligase adaptor function paralleling the STUB1–BBOX1 axis.\",\n      \"evidence\": \"IP/MS, Co-IP, proteasome inhibitor rescue, cycloheximide chase, OA mouse model\",\n      \"pmids\": [\"41067282\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of CRIP1 recruiting distinct E3 ligases to different substrates unknown\", \"Only single-lab validation\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"CRIP1 suppresses TFAM protein levels in melanoma, reducing mitochondrial DNA copy number and OXPHOS — adding mitochondrial biogenesis regulation to its functional repertoire.\",\n      \"evidence\": \"Stable overexpression/knockdown, OCR measurement, mitochondrial DNA assay, ATP assay in melanoma cells\",\n      \"pmids\": [\"39905216\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of TFAM suppression (transcriptional vs. post-translational) not determined\", \"Whether this involves ubiquitin-dependent degradation like BBOX1/MFGE8 is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for how the compact CRIP1 LIM domain engages its many diverse partners (p65, BRCA2, RAD51, STUB1, UBE3A, USP7, PA200, CB1); how arginine methylation by PRMT1/PRMT5 modulates partner selectivity; and whether CRIP1's E3 ligase adaptor function is a general scaffolding mechanism or restricted to specific substrates.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No co-crystal or cryo-EM structure of CRIP1 with any partner\", \"No systematic unbiased interactome in non-cancer cells\", \"Integration of methylation code with substrate/partner specificity untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 7, 10, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 8, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 5, 7, 9, 11, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 8, 15]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [7, 10, 12]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [\n      \"CRIP1–BRCA2–RAD51\",\n      \"CRIP1–USP7–PA200\"\n    ],\n    \"partners\": [\n      \"RELA\",\n      \"BRCA2\",\n      \"RAD51\",\n      \"STUB1\",\n      \"USP7\",\n      \"UBE3A\",\n      \"CNR1\",\n      \"HTRA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}